Eliquis (apixaban) is one of the most prescribed medications in the country, and also one of the most confusing to price. Search "Eliquis cost" and you'll find numbers ranging from $10 to $800 for the exact same drug — and both are correct, just for different people. Nothing about that is intuitive unless someone walks you through it. This guide breaks down what Eliquis costs with insurance, without insurance, through Medicare, and through the manufacturer's own savings programs, so you can figure out which price actually applies to you.
1. What Eliquis Costs Without Insurance
"Cash price" is what you'd pay at the counter with no insurance, no coupon, and no manufacturer program applied. For Eliquis, that's a steep number, because there's still no generic version competing on price.
| What you're paying for | Typical price range | Notes |
|---|---|---|
| 30-day supply (60 tablets, 5 mg) | $500–$800 | Standard twice-daily dosing |
| 90-day supply (180 tablets) | $1,400–$2,200 | Some pharmacies offer a modest per-pill discount at 90 days |
| Manufacturer list price (WAC) | ~$521–$606 | What BMS/Pfizer charge wholesalers, not what you pay at the counter |
| Per-tablet cash cost | ~$8–$13 | Based on 60 tablets per 30-day supply |
Prices vary by pharmacy chain and region, so treat this as a planning range. Independent pharmacies, big-box chains, and grocery-store pharmacies can differ by well over $100 for the same 30-day supply — it's worth calling around, or checking a drug price checker before you commit to one pharmacy.
2. What Eliquis Costs With Insurance
Insurance changes the math completely, but "I have insurance" isn't a single answer — what you pay depends on which kind you have.
- Commercial (employer or marketplace) insurance: Your plan sets a copay or coinsurance for Eliquis, often $20–$60 depending on its formulary tier. Stack that with the manufacturer's Co-Pay Card and most patients get to $10.
- Medicare Part D: Your cost-share is based on your specific plan's tier structure, applied against the new 2026 negotiated price of $231. Total annual out-of-pocket drug spending is capped at $2,100.
- Medicaid: Most state Medicaid programs cover Eliquis with a copay of $0–$4, though formularies and prior authorization rules vary by state.
- High-deductible health plans: Until you meet your deductible, you may pay close to the full negotiated rate your insurer has with the pharmacy — which can still be several hundred dollars a month early in the plan year.
The single biggest mistake people make: assuming "I have insurance" means "I automatically get the lowest price." It doesn't. The Co-Pay Card, Extra Help, and state-specific Medicaid rules all still require you to actively check and, in most cases, enroll.
3. Why Eliquis Is Still So Expensive
Eliquis was approved by the FDA in 2012, and a generic version — apixaban — was actually approved by the FDA back in 2019. Under normal patent timelines, that generic should already be on pharmacy shelves. It isn't, and won't be until April 1, 2028 at the earliest.
That gap exists because of patent litigation, not a safety or manufacturing issue. Bristol Myers Squibb and Pfizer hold a formulation patent that runs into 2031 (extended by pediatric exclusivity), and reached settlement agreements with would-be generic manufacturers that push the earliest legal launch date to April 2028, "subject to additional appeals and challenges." Until then, apixaban simply cannot be sold as a generic in U.S. pharmacies, regardless of FDA approval status.
You may see "November 2026" cited as a generic release date. That's when the core compound patent's extended term expires — a patent milestone, not the date a generic actually reaches your pharmacy. The settlement agreement, not the base patent, is what sets the real April 2028 launch window.
4. The Free 30-Day Trial Program
If you're newly prescribed Eliquis and don't have government insurance, this is worth checking before you fill anything.
- What it covers: Your first 30-day supply (up to 74 tablets, to account for loading-dose regimens) completely free.
- Who it's for: Patients newly prescribed Eliquis for an FDA-approved use, intended for more than 35 days of treatment.
- Who can't use it: Anyone enrolled in Medicare, Medicaid, or another government insurance program.
- How to use it: Activate the card through the official Eliquis savings site, then present it at a participating pharmacy along with your prescription.
- Limits: One use per person, cannot be combined with other coupons or programs, and the card must be activated and used by December 31, 2026.
5. The Eliquis Co-Pay Card
This is the main savings tool for anyone with commercial insurance.
- What it does: Lowers your out-of-pocket cost to as little as $10 for a 30-day supply, or $10 for your first 90-day supply, with later 90-day refills around $30.
- Duration: Benefits apply for up to 24 months from activation, with an annual savings cap.
- Who qualifies: Patients with commercial (private/employer) insurance that covers Eliquis. It is not usable with Medicare, Medicaid, VA, or TRICARE — federal law prohibits combining manufacturer copay assistance with federal health programs.
- How to enroll: Register at the official Eliquis savings site or call 1-855-354-7847, then activate before your pharmacy visit.
- Renewal: The card expires 24 months after activation; eligible patients can re-enroll once it lapses.
This is not insurance. The Co-Pay Card is a manufacturer discount layered on top of an existing commercial insurance plan — it reduces your copay, it doesn't replace your coverage.
6. Eliquis 360 Direct-to-Patient Program
For uninsured, cash-paying patients who've already used their free trial (or don't qualify for it), this bypasses the retail pharmacy entirely.
- What it does: Ships Eliquis directly to your home at more than 40% below the manufacturer's list price — bringing the effective cost to roughly $346 per month.
- Who it's for: Cash-paying patients with no insurance requirement, available across all 50 states and Puerto Rico.
- Why it matters: It's consistently cheaper than most retail cash prices and doesn't require income documentation or an approval wait.
7. Free Eliquis: Patient Assistance Foundation
If even $346 a month isn't workable, the Bristol Myers Squibb Patient Assistance Foundation (BMSPAF) provides Eliquis at no cost to income-qualified patients.
- Income limit: Household income generally at or below 300% of the federal poverty level.
- Insurance status: You must be uninsured or underinsured. Medicare patients must first apply for and be denied Extra Help before BMSPAF will consider their application.
- Documentation needed: Proof of income (tax return or recent pay stubs), proof of insurance status, a valid prescription, and documentation of out-of-pocket drug costs for the current year.
- How to apply: Apply at bmspaf.org or call 1-800-736-0003. Applying is free.
- Delivery: Medication ships directly to your home once approved.
This is a genuinely separate program from the Co-Pay Card and the Free Trial, and confusing the three is one of the most common mistakes patients make — more on that below. For a broader look at how these programs work across manufacturers, see our guide on what a patient assistance program actually is.
8. Medicare Part D and the 2026 Negotiated Price
2026 marks the first year Eliquis is subject to Medicare's new drug price negotiation authority under the Inflation Reduction Act, and it's one of the highest-spend drugs affected.
- Negotiated Maximum Fair Price: $231 for a 30-day supply, effective January 1, 2026 — roughly a 56% reduction from the prior list price of about $521.
- What this actually means for you: The Maximum Fair Price is what Medicare pays; your personal copay is still set by your specific Part D plan's formulary tier.
- The $2,100 out-of-pocket cap: Every Medicare Part D enrollee, including Medicare Advantage prescription drug (MA-PD) plans, is protected by a hard annual ceiling on drug costs. Once you hit $2,100 in out-of-pocket spending, covered medications cost nothing for the rest of the year.
- No Medicare enrollee should be paying $500+ a month for Eliquis going into 2026 — if your plan is charging close to full price, it's worth a call to confirm your formulary tier and check whether a different Part D plan would cost less during the next enrollment window.
For help understanding how this fits into your broader drug costs, see our full Medicare Part D 2026 changes guide.
9. Extra Help for Medicare Patients
Extra Help, Medicare's Low-Income Subsidy (LIS), can push your Eliquis cost even lower than the standard Part D structure.
- Standard Extra Help copay: No more than $12.65 per brand-name prescription (like Eliquis) and $5.10 for a generic, in 2026.
- Dual-eligible (Medicare + Medicaid, income below 100% FPL): Copays drop to $4.90 for brand-name drugs and $1.60 for generics.
- Premium and deductible: Extra Help pays your Part D premium up to a regional benchmark and eliminates your deductible entirely.
- Income limit: Roughly $23,475/year for an individual or $31,725/year for a married couple (about 150% of the federal poverty level) for full Extra Help in 2026.
- Automatic enrollment: If you already have Medicaid, SSI, or a Medicare Savings Program, you're automatically enrolled — no separate application required.
See our full Extra Help (LIS) eligibility guide for exact resource limits and how to apply if you're not automatically enrolled.
10. Eligibility Comparison
| Program | Insurance status required | Income documentation |
|---|---|---|
| Cash price (no program) | Any | None |
| Free 30-Day Trial | Cannot have Medicare, Medicaid, or other government coverage | None |
| Co-Pay Card | Commercial insurance only | None |
| Eliquis 360 Direct-to-Patient | Any, designed for cash-pay patients | None |
| Patient Assistance Foundation (BMSPAF) | Must be uninsured/underinsured; Medicare requires LIS denial first | Required, ~300% FPL |
| Medicare Part D + Extra Help | Medicare Part D required | Required, ~150% FPL for full subsidy |
11. Income Limit Comparison
| Household size | 150% FPL (Extra Help cutoff) | 300% FPL (BMSPAF cutoff) |
|---|---|---|
| 1 person | ~$23,475 | ~$46,950 |
| 2 people | ~$31,725 | ~$63,450 |
| 3 people | ~$39,975 | ~$79,950 |
| 4 people | ~$48,225 | ~$96,450 |
These figures update annually with federal poverty guidelines, so treat them as directional — confirm the current-year numbers directly on Social Security's Extra Help page or the BMSPAF application before assuming you do or don't qualify.
12. What Else These Programs Cover
| Program | Scope |
|---|---|
| Free 30-Day Trial | Eliquis only |
| Co-Pay Card | Eliquis only |
| Eliquis 360 Direct-to-Patient | Eliquis only |
| Patient Assistance Foundation | Multiple Bristol Myers Squibb medications; each drug is evaluated under the same income and insurance rules |
| Extra Help | Every drug on your Medicare Part D plan's formulary, not just Eliquis |
13. Cheaper Alternatives to Eliquis
Eliquis, Xarelto, Pradaxa, and Savaysa are all direct oral anticoagulants (DOACs) prescribed for similar conditions, but their cost pictures are no longer identical — some now have generic competition and Eliquis doesn't. This is a conversation to have with your prescriber, not a decision to make alone, since these drugs differ in dosing, monitoring needs, and interactions.
| Medication | Generic available? | Typical monthly cash price |
|---|---|---|
| Eliquis (apixaban) | No — blocked until April 2028 | $500–$800 |
| Xarelto (rivaroxaban) | Partially — some strengths only | $50–$90 (available generic strengths) to $550–$600 (brand-only strengths) |
| Pradaxa (dabigatran) | Yes | $45–$75 with a discount card; $394–$530 for brand |
| Savaysa (edoxaban) | No | Comparable to brand Eliquis pricing |
| Warfarin (Coumadin) | Yes, long-standing generic | $4–$15, plus regular INR blood-monitoring costs |
Why this matters: if cost is the main obstacle to staying on an anticoagulant, ask your prescriber directly whether Pradaxa or generic-strength Xarelto would be clinically appropriate for you. Switching blood thinners is a medical decision with real trade-offs in bleeding risk and dosing convenience — never done unilaterally, but always worth raising if price is putting doses at risk.
14. GoodRx vs. SingleCare vs. Inside Rx
Free discount cards can help, but they rarely beat what the manufacturer already offers for Eliquis specifically. A GoodRx coupon typically brings the cash price down to around $340–$400 for a 30-day supply — useful if you're uninsured and have already used your free trial, but still more expensive than the Co-Pay Card's $10 price for insured patients or BMSPAF's $0 for income-qualified patients. SingleCare and Inside Rx post similar ranges, with the specific "winner" varying by pharmacy and zip code. See our full GoodRx vs. Inside Rx vs. SingleCare comparison for how these networks actually differ.
Important: discount cards cannot be combined with insurance or with manufacturer programs. They're a separate cash-pay path, useful only when it's genuinely your cheapest option.
15. Step-by-Step: Getting the Lowest Price
Identify your coverage type
Commercial insurance, Medicare, Medicaid, or uninsured — this determines which programs are even available to you, since several exclude government-insured patients entirely.
If commercially insured, activate the Co-Pay Card before your first fill
Register online or by phone, then bring the activated card to the pharmacy along with your prescription — most patients land at $10.
If uninsured and newly prescribed, use the Free 30-Day Trial
This buys you a month at no cost while you sort out your next step, whether that's the direct-to-patient program or a BMSPAF application.
Check your income against 300% of the federal poverty level
If you're under that line and uninsured, apply for BMSPAF. It takes longer to process than the other options, so keep using the direct-to-patient program or a discount card while you wait.
If on Medicare, confirm your plan's actual tier cost — don't assume the $231 price applies to you directly
Call your Part D plan or check your Explanation of Benefits, and apply for Extra Help if your income qualifies.
Never skip or split doses to make a fill last longer
Under-dosing a blood thinner carries a real risk of stroke or clot. If cost is forcing you to ration, contact your prescriber or a patient assistance program immediately rather than adjusting your regimen on your own.
16. Approval and Processing Timelines
| Path | Typical timeline |
|---|---|
| Free 30-Day Trial activation | Same day — no approval wait |
| Co-Pay Card activation | Same day, once commercial coverage is confirmed |
| Eliquis 360 Direct-to-Patient enrollment | A few business days for first shipment |
| BMSPAF application | Typically 2–4 weeks, depending on documentation completeness and whether Medicare LIS denial proof is required |
| Extra Help application (Social Security) | Generally a few weeks; retroactive to your application date once approved |
17. Renewing Your Enrollment
- Co-Pay Card expires 24 months after activation; re-enrollment is available once it lapses, and terms can change year to year.
- Free 30-Day Trial is a one-time-per-person benefit — it does not renew.
- BMSPAF generally requires annual re-application with updated income and insurance documentation.
- Extra Help is typically reassessed annually by Social Security; report income or resource changes promptly to avoid a coverage gap.
- If your insurance status changes — you gain or lose a job-based plan, or you newly enroll in Medicare — recheck which program actually applies, since eligibility shifts immediately with coverage changes.
18. Common Mistakes to Avoid
Mistakes patients make
- Assuming the Co-Pay Card works with Medicare (it doesn't, by federal law)
- Confusing the Free 30-Day Trial with the Patient Assistance Foundation
- Paying full cash price without checking the direct-to-patient program first
- Not applying for Extra Help because they assume income is "too high"
- Rationing doses instead of contacting a prescriber or assistance program
What works well
- Checking coverage type before assuming which program applies
- Activating the Co-Pay Card before the very first fill, not after a high bill
- Re-checking Part D plan tiers every fall during open enrollment
- Keeping income documents ready before applying for BMSPAF
- Calling 1-800-MEDICARE or a benefits counselor when a plan's cost seems off
19. Pros and Cons of Each Option
Co-Pay Card ($10)
- Lowest possible price for insured patients
- No income check, same-day activation
- Works for up to 24 months
Co-Pay Card ($10)
- Commercial insurance only — no Medicare, Medicaid, VA, or TRICARE
- Requires re-enrollment after 24 months
- Annual savings cap applies
Patient Assistance Foundation (free)
- $0 cost for qualifying patients
- Ships directly to your home
Patient Assistance Foundation (free)
- Requires income documentation and annual renewal
- Slower approval than other options
- Medicare patients need an LIS denial first
20. Decision Tree: Which Path Fits You?
Between these three, uninsured patients almost never need to pay the full $500–$800 cash price.
21. Real Patient Scenarios
James, 58 — Newly diagnosed, uninsured Uninsured
James just started Eliquis after a DVT diagnosis and has no insurance. He activates the Free 30-Day Trial for his first fill at $0. Before his next fill, he applies for BMSPAF; his income is under 300% of the federal poverty level for his household size, so his ongoing prescriptions arrive free once approved. In the meantime, he uses the Direct-to-Patient program at roughly $346 a month so he doesn't have a gap in coverage.
Priya, 45 — Employer health plan Commercial insurance
Priya's employer plan puts Eliquis on a $45 copay tier. She activates the Co-Pay Card the same day she fills her first prescription, and her out-of-pocket cost drops to $10 for a 30-day supply — a savings she keeps for up to 24 months before needing to re-enroll.
Linda, 67 — Medicare Part D, moderate income Medicare
Linda's Part D plan places Eliquis on its highest brand tier, and she pays roughly $47 per 30-day supply after her plan applies the 2026 negotiated price. Her total drug spending for the year is capped at $2,100, so once she hits that threshold — likely by mid-year given her other prescriptions — Eliquis costs her nothing for the rest of the year.
Carlos, 71 — Medicare with Extra Help Extra Help / LIS
Carlos qualifies for full Extra Help based on his income and limited savings. His Eliquis copay is capped at $12.65 per 30-day fill regardless of his plan's formulary tier, and his Part D premium and deductible are both covered by the subsidy.
Related: Prior Authorization: How to Get Approved Faster
Some Part D and commercial plans require prior authorization before covering Eliquis at its lowest tier — this guide covers how to speed that process up.
Need help affording Eliquis or other prescriptions?
- What Is a Patient Assistance Program? 2026 Guide
- Drug Price Checker: Compare Pharmacies Near You
- Medicare Part D 2026 Changes: What to Know
- Extra Help (Low-Income Subsidy) Eligibility Guide
- Prior Authorization: How to Get Approved Faster
- GoodRx vs Inside Rx vs SingleCare: Which Saves More?
- Manufacturer Savings Cards: How They Work